CA Patent

CA2720096A1 — Pai-1 inhibitor

Assigned to Institute of Medicinal Molecular Design Inc IMMD · Expires 2009-10-15 · 17y expired

What this patent protects

The compound represented by the following formula (I) and the like have PAI-1 inhibition activity; wherein: R1 represents a C6-10 aryl group which may be substituted or the like; T represents a single bond or the like; m represents 0 or 1; when m is 0, G represents -N-C(=O)-C…

USPTO Abstract

The compound represented by the following formula (I) and the like have PAI-1 inhibition activity; wherein: R1 represents a C6-10 aryl group which may be substituted or the like; T represents a single bond or the like; m represents 0 or 1; when m is 0, G represents -N-C(=O)-CO2H or the like; when m is 1, G represents an oxygen atom or the like; R2 represents a C6-10 aryl group which may be substituted or the like; E represents the following formula (II) wherein one of R31, R32, R33 and R34 represents the formula R1-T-, each of the other three independently represents a hydrogen atom or the like, and R35 represents the formula -X-Y', a hydrogen atom or the like; X represents -CH2-or the like; Y' represents a carboxy group or the like; M represents a single bond or the like. (see formula)(see formula II)

Drugs covered by this patent

Patent Metadata

Patent number
CA2720096A1
Jurisdiction
CA
Classification
—
Expires
2009-10-15
Drug substance claim
No
Drug product claim
No
Assignee
Institute of Medicinal Molecular Design Inc IMMD
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.